Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL)’s traded shares stood at 3.28 million during the last session, with the company’s beta value hitting 1.79. At the close of
Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL)’s traded shares stood at 4.84 million during the last session, with the company’s beta value hitting 1.81. At the close of
In the last trading session, 2.21 million Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) shares changed hands as the company’s beta touched 1.81. With the company’s per share
In the last trading session, 3.14 million Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) shares changed hands as the company’s beta touched 1.79. With the company’s per share
In recent trading session, Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) saw 1.07 million shares changing hands at last check today with its beta currently measuring 1.79. Company’s
Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) has a beta value of 1.85 and has seen 3.18 million shares traded in the last trading session. The ZNTL stock
Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) has a beta value of 1.85 and has seen 0.82 million shares traded in the recent trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
